Head and Neck Cancer Market: Increase in Patient Population to Propel Market

Wilmington, Delaware, United States, Transparency Market Research Inc.: Transparency Market Research (TMR) has published a new report titled, “Head and Neck Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global head and neck cancer market was valued at US$ 933.3 Mn in 2017 and is anticipated expand at a CAGR of 9.2% from 2018 to 2026. Growth of the pharmaceutical industry, government initiatives, increase in health care expenditure, surge in product approval, and rise in patient population are projected to augment the global market from 2018 to 2026.

Increase in Patient Population to Propel Market

Cancers of the head and neck are categorized depending on the location. These areas include oral cavity, pharynx, larynx, paranasal sinuses & nasal cavity, and salivary glands. Increase in consumption of alcohol and tobacco is a major cause of head and neck cancer. An estimated 75% of head and neck cancers is caused due to consumption of alcohol and tobacco.

Request a PDF Sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=22919

Increase in the number of head and neck cancer patients across the world is anticipated to drive demand for therapeutics. According to the American Society of Clinical Oncology (ASCO), head and neck cancer accounted for nearly 4% of all cancers in the U.S. in 2017. Moreover, nearly 65,000 individuals will develop head and neck cancer in the near future.

Rapidly Growing Health Care and Pharmaceutical Industries

Drug class such as anti-PD-1 monoclonal antibodies is routinely used in the treatment of head and neck (HNC) cancer. The global head and neck cancer market has witnessed an increase in new product approvals in the past few years. This is anticipated to propel the global market and provide lucrative opportunities during the forecast period.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22919

For instance, in November 2016, Bristol-Myers Squibb Company announced the U.S. Food and Drug Administration (FDA) approval for Opdivo (nivolumab) injection for intravenous use in the treatment of patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

High Failure Rates of Late-stage Products in Clinical Trials to Restrain Market

Rise in scientific and technological advancements in R&D and manufacturing processes is expected to increase the efficiency of drug development. However, a significant number of clinical trials fail to meet desired results. This acts as a major restraint of the global head and neck cancer market and in turn limits the entry of new players. For instance, in 2017, phase 3 trial designed to evaluate pembrolizumab for the treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma failed to meet its pre-specified primary endpoint of overall survival.

Request for Analysis of COVID19 Impact on Head and Neck Cancer Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=22919

Asia Pacific Market to Register Exponential Growth

In terms of revenue, the head and neck cancer market in Asia Pacific is projected to expand at a CAGR of 10.2% during the forecast period. Rapidly increasing patient population in the region is expected to boost demand for therapeutics for the treatment of head and neck cancer, which in turn is likely to drive the market from 2018 to 2026.

Growth of the biopharmaceutical industry and government initiatives in the region are anticipated to provide lucrative opportunities for manufacturers in the next few years. According to the Indian Council for Medical Research (ICMR), 90% of oral cancer patients in rural areas belong to the lower or lower-middle socio-economic class.

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=22919

Merck KGaA and Bristol-Myers Squibb Company to Lead Market

The report also provides profiles of leading players operating in the global head and neck cancer market. These include Sanofi, Pfizer, Eli Lilly and Company, Merck KgaA, Bristol-Myers Squibb Company, Bayer AG, Galera, Fresenius Kabi, and Teva Pharmaceuticals. Increase in mergers & acquisitions, strategic collaborations, and new product launches are expected to drive the global market during the forecast period. In July 2018, Merck announced the phase III trial for KEYTRUDA (Pembrolizumab) anti-PD-1 therapy for first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

More Trending Reports by Transparency Market Research –

Oncology Biosimilars Market: Oncology Biosimilars Market (Drug Class - G-CSF, Monoclonal Antibodies, and Hematopoietic Agents; Disease Indication - Breast Cancer, Non-small Cell Lung Cancer, Colorectal Cancer, Neutropenia, and Blood Cancer; and Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Cancer Immunotherapy Market: Cancer Immunotherapy Market (Therapy Type: Monoclonal Antibodies, Immune Checkpoint Inhibitors, PD-1/PD-L1, CTLA-4, Immune System Modulators, Cancer Vaccines, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Implantable Medical Devices Market: Implantable Medical Devices Market (Product Type: Orthopedic Implants [Reconstructive Joint Replacement and Spinal Implants], Cardiovascular Implants, Dental Implants, Intraocular Lens, Breast Implants, and Other Implants) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Prostate Cancer Therapeutics Market: Prostate Cancer Therapeutics Market (Therapy: Hormone Therapy, Chemotherapy, Biologic Therapy, and Targeted Therapy; Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Sales, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Lyophilized Injectable Drugs Market: Lyophilized Injectable Drugs Market (Type of Packaging -Single-use Vials, Point-of-care Reconstitution, Specialty Packaging; Type of Delivery - Prefilled Diluent Syringes, Proprietary Reconstitution Devices, Single-step Devices, Multi-step Devices; Indication - Autoimmune Diseases, Infectious Diseases, Metabolic Conditions; End user - Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Osteoarthritis Drugs Market: Osteoarthritis Drugs Market (Drug Class - Corticosteroids, NSIADs and Others, Viscosupplementation Agents; Route of Administration - Oral, Parenteral, Topical; Distribution Channel - Hospital Pharmacies, Retail pharmacies, Online pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Adult Malignant Glioma Therapeutics Market: Adult Malignant Glioma Therapeutics Market (Type - Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma; Therapy - Chemotherapy, Targeted Drug Therapy, Radiation Therapy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Basal Cell Carcinoma Treatment Market: Basal Cell Carcinoma Treatment Market (Treatment type - Surgical (Surgical Excision, Electrodessication & Cutterage, Moh's Surgery, and Cryosurgery), Drugs (Topical Treatment, Advanced Medication, and Other), and Others (Radiation Therapy, Photodynamic Therapy, and Laser Therapy); End-users- Hospitals, Specialty Clinics, and Others: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 – 2025

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

Back to news